Skip to main content
. 2023 Sep 16;7:93. doi: 10.1038/s41698-023-00447-z

Fig. 3. ICAM1 ADCs selectively ablating human CCA cells in vitro.

Fig. 3

a Schematic diagram of the structure of an ICAM1-DXd. b Schematic diagram of the structure of an ICAM1-MMAE. c In vitro cytotoxicity of ICAM1 antibody (ICAM1 mAb), two ICAM1 ADCs (ICAM1-MMAE and ICAM1-DXd), and one chemotherapy drug Gemcitabine against a panel of six human CCA cell lines and normal 293T cells.